Pharmacopius Drugs Private Limited, a active private limited company, was established on 13 July 2005 in Kottayam, Kerala, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24232KL2005PTC018418. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.48 M.
It upholds a compliant status. Employing 33 professional, Its leadership includes Aju Varghese (Managing Director), Thekkemadathil Ramakrishnan Manikandan (Managing Director). Past directors included Nava Kumar Narayanan, Meena Saji, Aju Varghese. It holds ₹8.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Xi/605-D, First Floor, Parayil Building, Girideepam Road Side, Vijayapuram Pancha, Yath,, Kottayam, Kerala, 686010.
U24232KL2005PTC018418
018418
13 July 2005
₹0.50 M
₹0.48 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Pharmacopius Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aju Varghese | Managing Director | 13 Jul 2005 | Current |
| Thekkemadathil Ramakrishnan Manikandan | Managing Director | 13 Jul 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Jan 2009 | Past |
| Pramod Abcsdd | Managing Director | 13 Oct 2022 | Past |
| Pramod Abcsdd | Director | 13 Oct 2022 | Past |
| Pramod Abcsdd | Director | 09 Jul 2008 | Past |
| Pramod Abcsdd | Director | 13 Oct 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pharmacopius Drugs Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 8.18% increase. The company also saw a substantial improvement in profitability, with a 15.11% increase in profit. The company's net worth moved up by a moderate rise of 7.28%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Pharmacopius Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹8,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Feb 2025 | Others | ₹8.00 M | Open |
Explore comprehensive loan charge details -
Pharmacopius Drugs has a workforce of 33 employees as of Nov 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Pharmacopius Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmacopius Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 8.00 M with Charge ID 101065703 was registered on 13 Feb 2025. was recorded as a recent event.
The activity Pharmacopius Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Pharmacopius Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
The activity Aju Varghese was appointed as a Managing Director was appointed as a Managing Director on 13 Jul 2005 & has been associated with this company since 20 years 5 months . was completed.
The activity Thekkemadathil Ramakrishnan Manikandan was appointed as a Managing Director was appointed as a Managing Director on 13 Jul 2005 & has been associated with this company since 20 years 5 months . was completed.
Pharmacopius Drugs Private Limited was registered on 13 Jul 2005 with Roc Ernakulam & aged 20 years 5 months as per MCA records. was recorded as a recent event.
The CIN of Pharmacopius Drugs Private Limited is U24232KL2005PTC018418.
Pharmacopius Drugs Private Limited is headquartered at Xi/605-D, First Floor, Parayil Building, Girideepam Road Side, Vijayapuram Pancha, Yath,, Kottayam, Kerala, 686010.
Pharmacopius Drugs Private Limited was incorporated on 13 July 2005.
The current directors of Pharmacopius Drugs Private Limited are
The primary industry of Pharmacopius Drugs Private Limited is Manufacturing.
Pharmacopius Drugs Private Limited is unlisted.
The authorized capital of Pharmacopius Drugs Private Limited is ₹0.50 M, and the paid-up capital is ₹0.48 M.
The compliance status of Pharmacopius Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX